Holy Stone Healthcare Co., Ltd.
4194
Rank in Stocks
#24678
Holy Stone Healthcare Co., Ltd., together with its subsidiaries, develops and... Holy Stone Healthcare Co., Ltd., together with its subsidiaries, develops and sells hyaluronic acid-related therapeutic products in Taiwan. The company offers RenehaVis and SportVis, which are injectable medical devices for osteoarthritis and soft tissue injuries; TRUD, a medical device that contains a mixture of hyaluronic acid used for the treatment and prevention of ulcerative colitis in inflammatory bowel disease (IBD); and GAF, a gel for anal fissure healing. It also develops IBD98-M, an oral capsule that is in a Phase IIa trial for ulcerative colitis; CA102N, a receptor-targeted chemotherapy that is in a Phase II trial for metastatic colorectal cancer, as well as in a pre-clinical stage for pancreatic ductal adenocarcinoma and a discovery stage for triple-negative breast cancer; ND108E, a CNS-targeted HA conjugate that is in a pre-clinical trial for Alzheimer’s disease; AMD112, a non-invasive HA-conjugated small molecule therapy that is in a pre-clinical trial for wet age-related macular degeneration and other neovascular retinal diseases; and HylCaryo, a hyaluronic acid (HA)-derived nanoparticle platform in a discovery stage. In addition, the company engages in general investment; development and sale of medical devices; biotechnology services; and patent application for pharmaceutical products. Holy Stone Healthcare Co., Ltd. was founded in 2001 and is headquartered in Taipei, Taiwan.
Share Price
$0.20119743
Last synced: 2026-11-10
Market Cap
$31.34M
Change (1 day)
8.02%
Change (1 year)
-25.76%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Holy Stone Healthcare Co., Ltd. (4194)
Category
Healthcare
Operating Margin for Holy Stone Healthcare Co., Ltd. (4194)
Operating Margin as of November 2026 TTM: 0.00%
According to Holy Stone Healthcare Co., Ltd.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Holy Stone Healthcare Co., Ltd. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | -100.00% |
| 2024 | -159.82% | 31.18% |
| 2023 | -121.83% | 121.03% |
| 2022 | -55.12% | -31.81% |
| 2021 | -80.83% | 39.07% |
| 2020 | -58.12% | -36.65% |
| 2019 | -91.75% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 62.34% | - |
US
|
|
| 31.60% | - |
SE
|
|
| 30.13% | - |
FR
|
|
| 29.76% | - |
HK
|
|
| 30.46% | - |
IT
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Holy Stone Healthcare Co., Ltd.'s operating margin
What was Holy Stone Healthcare Co., Ltd.'s operating margin in 2025?
In 2025, Holy Stone Healthcare Co., Ltd.'s operating margin was 0.00%, compared with -159.82% in 2024.
How has Holy Stone Healthcare Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Holy Stone Healthcare Co., Ltd.'s operating margin was highest in 2025 (0.00%) and lowest in 2024 (-159.82%).
How does Holy Stone Healthcare Co., Ltd.'s operating margin compare with similar companies?
Holy Stone Healthcare Co., Ltd.'s operating margin (0.00%) is lower than that of all 5 similar companies listed above. The highest among them is Royalty Pharma plc, with 62.34%.